Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol)
1995
Influence of Drug-to-Lipid Ratio on Drug Release Properties and Liposome Integrity in Liposomal Doxorubicin Formulations
2008
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Liposomes, a promising strategy for clinical application of platinum derivatives
2013
Colloidal drug carriers: achievements and perspectives
2003
In vitro tests to predict in vivo performance of liposomal dosage forms
1993
Increase in phospholipase A 2 activity towards lipopolymer-containing liposomes
1998
Ultrasound triggered release of cisplatin from liposomes in murine tumors
2009
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
1991
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin
1991
Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers
2002
Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy
2011
Challenges in Development of Targeted Liposomal Therapeutics
2012
Influence of dose on liposome clearance: critical role of blood proteins
1996
Stability of liposomal doxorubicin formulations: Problems and prospects
1993
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies
1996
Prolongation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polyethylene Glycol-Derivatized Phospholipid: Pharmacokinetic Studies in Rodents and Dogs
1993
Enhancement of the in vivo circulation lifetime of l-α-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization
1997
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation
1993
Rate of biodistribution of STEALTH® liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity
2002
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy
2003
Tumor targeting using anti-her2 immunoliposomes
2001
Pharmacokinetics of Pegylated Liposomal Doxorubicin
2003
Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*
2003
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity
1994
Nanocarriers for delivery of platinum anticancer drugs
2013
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times
1991
Localised drug release using MRI-controlled focused ultrasound hyperthermia
2010
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating
1991
Preparation and characterization of liposomes as therapeutic delivery systems: a review
1995
Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties
2009
Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration
2010
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Preparation of Large Monodisperse Vesicles
2009 StandoutNobel
The golden age: gold nanoparticles for biomedicine
2011 Standout
Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
2011
Large liposomes containing ganglioside GM1 accumulate effectively in spleen
1991
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
2001
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma
2001
Aging brain: effect of acetyl-l-carnitine treatment on rat brain energy and phospholipid metabolism. A study by31P and1H NMR spectroscopy
1990
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies
2003
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer
2002
Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer
2008
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
2003
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion
1997
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
2007
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases
1993
Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci
2002
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
2014
Characterization of In Vivo Immunoliposome Targeting to Pulmonary Endothelium
1990
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
State-of-the-art materials for ultrasound-triggered drug delivery
2014
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma
2004
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Liposomal nanostructures for photosensitizer delivery
2011
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.
1995
The rise and rise of drug delivery
2005
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma
1996
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
2009
Clearance properties of liposomes involving conjugated proteins for targeting
1998
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
2014
Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes upon Repeated Injection
2001
Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery
2002
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
2019
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Accumulation of Liposomal Lipid and Encapsulated Doxorubicin in Murine Lewis Lung Carcinoma: The Lack of Beneficial Effects by Coating Liposomes with Poly(ethylene glycol)
1997
Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes
1994
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs
1999
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Sterically stabilized liposomes
1992
Increased liposome extravasation in selected tissues: effect of substance P.
1996
Quick Synthesis of Lipid−Polymer Hybrid Nanoparticles with Low Polydispersity Using a Single-Step Sonication Method
2010
Pharmacokinetics and Biodistribution of Nanoparticles
2008
Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles
2011 Standout
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
2001
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Polymeric nanovehicles for anticancer drugs with triggering release mechanisms
2007
<emphasis emphasistype="italic">In Vitro</emphasis> Analysis of Cisplatin Functionalized Magnetic Nanoparticles in Combined Cancer Chemotherapy and Electromagnetic Hyperthermia
2008
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
2018
Nonviral Vectors for Gene Delivery
2008 Standout
Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes.
1994
The controlled delivery of drugs to the lung
1995
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes
2000
From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy
2003
Cyclodextrin Drug Carrier Systems
1998 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location
2017
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
1991
Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo.
2002
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
1995
Toxicity of drug carriers to the mononuclear phagocyte system
1988
Review Hyperthermia and liposomes
1999
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
New frontiers in aerosol delivery during mechanical ventilation.
2004
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo
1998
Liposomal daunorubicin as treatment for Kaposi's sarcoma.
2007
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
2001
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Is half‐life of circulating liposomes determined by changes in their permeability?
1982
Biodegradable Long-Circulating Polymeric Nanospheres
1994 StandoutScience
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes
2009
Liposome application: problems and prospects
2001
The Effects of Nanoparticle Drug Loading on the Pharmacokinetics of Anticancer Agents
2015
Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck
2001
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.
1992
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
1987
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Sterically stabilized liposome therapeutics
1995
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.
1992
Nanocapsules of Platinum Anticancer Drugs: Development Towards Therapeutic Use
2009
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
2010
Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection
1985
Polymer Vesicles
2002 StandoutScience
Works of R.M. Abra being referenced
Clearance of Phosphatidylcholine and Cholesterol from Liposomes, Liposomes Loaded with Metaproterenol, and Rabbit Surfactant from Adult Rabbit Lungs
1989
Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes
1999
Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
2000
Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance
2001
Influence of tumour size on uptake of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model
2000
Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts
1994
Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes
1994
THE NEXT GENERATION OF LIPOSOME DELIVERY SYSTEMS: RECENT EXPERIENCE WITH TUMOR-TARGETED, STERICALLY-STABILIZED IMMUNOLIPOSOMES AND ACTIVE-LOADING GRADIENTS
2002
Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes
1993
Factors Affecting the Release Rate of Terbutaline from Liposome Formulations After Intratracheal Instillation in the Guinea Pig
1992
Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy
1994
Preparation and Characterization of Liposomal Doxorubicin for Human Use
1992
The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker.
1982
A novel pathway for phosphatidylcholine catabolism in rat brain homogenates
1975
The effect of lipid composition upon the encapsulation and in vitro leakage of metaproterenol sulfate from 0.2μm diameter, extruded, multilamellar liposomes
1990
Liposome Disposition In Vivo VI: Delivery to the Lung
1984
Liposome disposition in vivo: effects of pre-dosing with lipsomes.
1980
Murine plasma fibronectin depletion after intravenous injection of liposomes
1987
Liposome disposition in vivo
1981